Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
暂无分享,去创建一个
Nicola Zamboni | Ravi Sachidanandam | Yuri Lazebnik | Peter Oefner | R. Sachidanandam | P. Oefner | Y. Lazebnik | Nicola Zamboni | M. Yuneva | Mariia Yuneva
[1] P. Gaynon,et al. Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961). , 2004, Anticancer research.
[2] H. Forman,et al. Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines. , 1997, European journal of cancer.
[3] B. Fuchs,et al. Stressing out over survival: glutamine as an apoptotic modulator. , 2006, The Journal of surgical research.
[4] L. Reitzer,et al. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. , 1979, The Journal of biological chemistry.
[5] R. Curi,et al. Molecular mechanisms of glutamine action , 2005, Journal of cellular physiology.
[6] E. Rogakou,et al. DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139* , 1998, The Journal of Biological Chemistry.
[7] J. Matés,et al. Co-expression of glutaminase K and L isoenzymes in human tumour cells. , 2005, The Biochemical journal.
[8] M. Tomita,et al. Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. , 2003, Journal of proteome research.
[9] R. Hebbel,et al. alpha-Ketoacids scavenge H2O2 in vitro and in vivo and reduce menadione-induced DNA injury and cytotoxicity. , 1995, The American journal of physiology.
[10] G. Friedell,et al. The proportionality of glutaminase content to growth rate and morphology of rat neoplasms. , 1969, Cancer research.
[11] H. Morris,et al. Glutaminase activities and growth rates of rat hepatomas. , 1969, Cancer research.
[12] W. Zong,et al. How do cancer cells acquire the fuel needed to support cell growth? , 2005, Cold Spring Harbor symposia on quantitative biology.
[13] Eyal Gottlieb,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[14] R. D. De Abreu,et al. Reversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenine. , 1995, Biochemical pharmacology.
[15] M. Simpson,et al. Structural Insights into Histone Demethylation by JMJD2 Family Members , 2006, Cell.
[16] R. L. Hawkins,et al. Lactate: A major product of glutamine metabolism by human diploid fibroblasts , 1980, Journal of cellular physiology.
[17] K. Wirtz,et al. "Wages of fear": transient threefold decrease in intracellular ATP level imposes apoptosis. , 2004, Biochimica et biophysica acta.
[18] D. Green,et al. The Pathophysiology of Mitochondrial Cell Death , 2004, Science.
[19] J. Grem,et al. Metabolism and action of amino acid analog anti-cancer agents. , 1990, Pharmacology & therapeutics.
[20] O. H. Lowry,et al. The measurement of pyridine nucleotides by enzymatic cycling. , 1961, The Journal of biological chemistry.
[21] E. Prochownik,et al. MYC oncogenes and human neoplastic disease , 1999, Oncogene.
[22] Hans Ulrich Bergmeyer,et al. Methods of Enzymatic Analysis , 2019 .
[23] A. Ladurner,et al. Rheostat control of gene expression by metabolites. , 2006, Molecular cell.
[24] Z. Kovačević. Possibility for the transfer of reducing equivalents from the cytosol to the mitochondrial compartment in Ehrlich ascites tumor cells by the malate-aspartate shuttle. , 1972, European journal of biochemistry.
[25] M. Butler,et al. Profile of energy metabolism in a murine hybridoma: Glucose and glutamine utilization , 1994, Journal of cellular physiology.
[26] J. Cleveland,et al. c-Myc Augments Gamma Irradiation-Induced Apoptosis by Suppressing Bcl-XL , 2003, Molecular and Cellular Biology.
[27] H. R. Zielke,et al. Glutamine: a major energy source for cultured mammalian cells. , 1984, Federation proceedings.
[28] Z. Kovačević,et al. Control and function of the transamination pathways of glutamine oxidation in tumour cells. , 1991, The Biochemical journal.
[29] G. Hannon,et al. MaRX: An Approach to Genetics in Mammalian Cells , 1999, Science.
[30] S. Pelengaris,et al. The many faces of c-MYC. , 2003, Archives of biochemistry and biophysics.
[31] M. Eilers,et al. Transcriptional regulation and transformation by Myc proteins , 2005, Nature Reviews Molecular Cell Biology.
[32] L. Baggetto,et al. Deviant energetic metabolism of glycolytic cancer cells. , 1992, Biochimie.
[33] R. DePinho,et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.
[34] P. Hammerman,et al. Beginnings of a signal-transduction pathway for bioenergetic control of cell survival. , 2004, Trends in biochemical sciences.
[35] S. Schreiber,et al. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] C. Townsend,et al. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. , 2003, Cancer research.
[37] A. Meister,et al. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). , 1979, The Journal of biological chemistry.
[38] C. Dang,et al. Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* , 2000, The Journal of Biological Chemistry.
[39] David G. Watson,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[40] C. Nathan,et al. Secretion of pyruvate. An antioxidant defense of mammalian cells , 1987, The Journal of experimental medicine.
[41] T. Turkington,et al. Clinical applications of PET in oncology. , 2004, Radiology.
[42] L. Reitzer,et al. The continuous growth of vertebrate cells in the absence of sugar. , 1981, The Journal of biological chemistry.
[43] M. Loda,et al. c-Myc phosphorylation is required for cellular response to oxidative stress. , 2006, Molecular cell.
[44] B Crabtree,et al. The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells , 1985, Bioscience reports.
[45] S. Fulda,et al. HIF-1-Regulated Glucose Metabolism: A Key to Apoptosis Resistance? , 2007, Cell cycle.
[46] W. Souba,et al. Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[47] A. Lehninger,et al. The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme. , 1984, The Journal of biological chemistry.
[48] L. Kaczmarek,et al. Proapoptotic N-truncated BCL-xL protein activates endogenous mitochondrial channels in living synaptic terminals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[49] M. Guppy,et al. Cancer metabolism: facts, fantasy, and fiction. , 2004, Biochemical and biophysical research communications.
[50] N. Sonenberg,et al. Translational control in stress and apoptosis , 2005, Nature Reviews Molecular Cell Biology.
[51] G. Evan,et al. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. , 1995, Nucleic acids research.
[52] C. Sen,et al. Flow cytometric determination of cellular thiols. , 1999, Methods in enzymology.
[53] W. Ho,et al. A convenient one-step extraction of cellular ATP using boiling water for the luciferin-luciferase assay of ATP. , 2002, Analytical biochemistry.
[54] Y. Lazebnik,et al. Oncogene-dependent apoptosis is mediated by caspase-9. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[55] G. Wahl,et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. , 2002, Molecular cell.
[56] Didier Picard,et al. Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells , 1989, Nature.
[57] Kathryn A. O’Donnell,et al. Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis , 2005, Molecular and Cellular Biology.
[58] C. Dang,et al. A unique glucose-dependent apoptotic pathway induced by c-Myc. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[59] P. Guérin,et al. Oxidative stress is not required for the induction of apoptosis upon glutamine starvation of Sp2/0-Ag14 hybridoma cells. , 2006, European journal of cell biology.
[60] Y. Lazebnik,et al. Caspases Disrupt the Nuclear-Cytoplasmic Barrier , 2000, The Journal of cell biology.
[61] S. Williams,et al. A comparison of cell and tissue extraction techniques using high‐resolution 1H‐NMR spectroscopy , 2002, NMR in biomedicine.
[62] S. Grimm,et al. The tumor suppressor cybL, a component of the respiratory chain, mediates apoptosis induction. , 2003, Molecular biology of the cell.
[63] Fionnuala Morrish,et al. c-MYC apoptotic function is mediated by NRF-1 target genes. , 2003, Genes & development.
[64] S. Nagata,et al. Involvement of an ICE-like protease in Fas-mediated apoptosis , 1995, Nature.
[65] D. Sabatini. mTOR and cancer: insights into a complex relationship , 2006, Nature Reviews Cancer.
[66] Ken Garber,et al. Energy Deregulation: Licensing Tumors to Grow , 2006, Science.
[67] John M Sedivy,et al. A Large Scale Genetic Analysis of c-Myc-regulated Gene Expression Patterns* 210 , 2003, The Journal of Biological Chemistry.
[68] M. Löffler,et al. Uridine, but not cytidine can sustain growth of Ehrlich ascites tumor cells in glucose-deprived medium with altered proliferation kinetics. , 1985, European journal of cell biology.
[69] L. Cantley,et al. Ras, PI(3)K and mTOR signalling controls tumour cell growth , 2006, Nature.
[70] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[71] M. Medina,et al. Glutamine and cancer. , 2001, The Journal of nutrition.
[72] P. Bouillet,et al. Bim is a suppressor of Myc-induced mouse B cell leukemia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.